Sep 16 |
Puma Biotechnology rises on appeal of AstraZeneca Tagrisso patent dispute
|
Sep 16 |
Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago
|
Sep 3 |
Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
Aug 15 |
Puma Biotech confirms court ruling on patent dispute with AstraZeneca
|
Aug 14 |
Federal Judge Rejects Patent Claims Supporting Puma Biotechnology's Breast Cancer Drug; Company Shares Down After Hours
|
Aug 14 |
Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso
|
Aug 9 |
Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye
|
Aug 4 |
Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations
|
Aug 3 |
Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report
|
Aug 2 |
Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected
|